Decrease in IL-4 measured by standard ELISA. by Albert S. Jun (231619)

“…Each ELISA value is an average of two measurements. The decrease in IL-4 in the keratoconus pool (7.6±5 pg/ml), compared to controls (14.2±8.6 pg/ml) was statistically significant (p≤0.05, Mann-Whitney test). …”

MiR-371-5p promoted the growth of pancreatic cancer cells <i>in vitro</i> and <i>in vivo</i>. by De He (497662)

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

TIMP-4 overexpression decreases cell viability. by Floria Lizarraga (785275)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

The effect of glibenclamide on channel activity at +20, 0 and -20 mV. by Sajjad Salari (736104)

“…The addition of 50 μM glibenclamide resulted in a decreased current jump amplitude and a reduction in P_o. 100 μM glibenclamide caused a total channel inhibition at +20 and 0 mV (n = 5), but was ineffective at -20 mV. …”

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Nampt inhibition leads to decrease in Rev-erb alpha expression and glucagon secretion in alphaTC1-9 cells and pancreatic alpha cells. by Elaine Vieira (174928)

“…<p>(<b>A</b>) <i>Sirt1</i> gene expression in alphaTC1-9 cells treated with 0.5 mM, 11 mM glucose or 500 nM FK 866 for 6 hours (n = 7). …”

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

(A) FACS analysis of cell surface markers on untreated or 5 nM Bortezomib treated mature dendritic cells. by Daniela Grabher (383863)

“…<p>Maturation marker expression (CD80, CD83 and CD86, MHC class I and MHC class II) on mature dendritic cells and mature dendritic cells treated with 5 nM Bortezomib were measured. Maturation markers show no difference when treated with 5 nM Bortezomib. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)